
07-20-2016, 01:18 AM
|
|
Administrator
|
|
تاريخ التسجيل: Sep 2012
المشاركات: 3,727,761
|
|
BRIEF-Sarepta Therapeutics Q2 **n-GAAP loss per share $1.19 excluding items
BRIEF-Sarepta Therapeutics Q2 **n-GAAP loss per share .19 excluding items
* ** revenue was recognized for three months ended June 30,2016 and 2015
|